Dulanto-Zabala D

Idioma: Español
Referencias bibliográficas: 5
Paginas: 30-32
Archivo PDF: 70.69 Kb.

FRAGMENTO

INTRODUCCIÓN

El número de antihipertensivos comercializados, en todos los países, es muy elevado. El anestesiólogo debe conocer las pautas actuales del tratamiento antihipertensivo, las interacciones con los fármacos anestésicos, y las recomendaciones de mantenimiento o suspensión del tratamiento antes de una anestesia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for non cardiac surgery executive summary a report of the American College of Cardiology/ American Hearth Association Task Force on practice guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for non cardiac surgery). Circulation 2002;105:1257-1267.

2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Coverting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic The Antihypertensive and Lipid-Lowering Treatment to prevent Hearth Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.

3. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanzyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major non cardiac surgery. Circulation 1999;100:1043-1049.

4. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994;81:299-307.

5. 5 . Boccara G, et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with rennin-angiotensin system inhibitors. Anesthesiology 2003;98:1338-1344.